Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | December 29, 2022 01:31pm

Gainers

  • Hoth Therapeutics (NASDAQ:HOTH) shares moved upwards by 143.4% to $10.71 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 20.7 million shares, making up 17470.8% of its average full-day volume over the last 100 days. The company's market cap stands at $13.9 million.
  • Quotient (NASDAQ:QTNT) shares increased by 93.95% to $0.45. Trading volume for Quotient's stock is 38.6 million as of 12:30 EST. This is 4861.7% of its average full-day volume over the last 100 days. The company's market cap stands at $1.5 million.
  • Palisade Bio (NASDAQ:PALI) shares moved upwards by 53.59% to $2.78. The current volume of 6.2 million shares is 466.2% of Palisade Bio's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $3.9 million.
  • Baudax Bio (NASDAQ:BXRX) stock increased by 49.56% to $3.44. As of 12:30 EST, Baudax Bio's stock is trading at a volume of 27.5 million, which is 4347.0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.9 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock rose 40.46% to $8.99. Trading volume for Reshape Lifesciences's stock is 456.3K as of 12:30 EST. This is 2261.5% of its average full-day volume over the last 100 days. The company's market cap stands at $4.3 million.
  • Nuwellis (NASDAQ:NUWE) stock moved upwards by 33.7% to $12.26. Trading volume for Nuwellis's stock is 3.8 million as of 12:30 EST. This is 2655.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.8 million.

Losers

  • F-star Therapeutics (NASDAQ:FSTX) stock declined by 39.3% to $4.17 during Thursday's regular session. The current volume of 2.2 million shares is 833.8% of F-star Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $91.5 million.
  • Jasper Therapeutics (NASDAQ:JSPR) shares decreased by 22.47% to $0.46. The current volume of 725.1K shares is 1254.7% of Jasper Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $16.9 million.
  • Rubius Therapeutics (NASDAQ:RUBY) stock fell 18.61% to $0.19. Trading volume for Rubius Therapeutics's stock is 2.3 million as of 12:30 EST. This is 246.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.5 million.
  • PetVivo Hldgs (NASDAQ:PETV) shares decreased by 14.88% to $1.66. The market value of their outstanding shares is at $16.7 million.
  • Scopus BioPharma (NASDAQ:SCPS) stock fell 14.42% to $0.09. The company's market cap stands at $1.9 million.
  • Minerva Surgical (NASDAQ:UTRS) shares fell 14.12% to $0.23. Trading volume for Minerva Surgical's stock is 1.3 million as of 12:30 EST. This is 199.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BXRX FSTX HOTH JSPR NUWE PALI PETV QTNT RSLS RUBY SCPS UTRS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist